| Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease (NCT04595266) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2021-06-29 |
| Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1) (NCT04599478) | Yale University | 2021-06-29 |
| Targeting Metabolic Flexibility in Amyotrophic Lateral Sclerosis (ALS) (NCT04788745) | The University of Queensland | 2021-06-29 |
| Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Parent Study (NCT04887870) | Mirati Therapeutics Inc. | 2021-06-29 |
| A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL) (NCT04914741) | Peter MacCallum Cancer Centre, Australia | 2021-06-29 |
| Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE) (NCT04411654) | Prevail Therapeutics | 2021-06-29 |
| Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy (NCT04816916) | Axcella Health, Inc | 2021-06-29 |
| Post-operative Analgesic Effect of Oral Nefopam (NCT04576078) | Hospices Civils de Lyon | 2021-06-29 |
| A Study to Evaluate the Safety and Efficacy of Selinexor With or Without Pembrolizumab Versus Standard of Care in Previously Treated Metastatic Colorectal Cancer With RAS Mutations (NCT04854434) | Karyopharm Therapeutics Inc | 2021-06-29 |
| Trial of Therapeutic Hypothermia in Patients With ARDS (NCT04545424) | University of Maryland, Baltimore | 2021-06-29 |
| Efficacy of Inhaled Therapies in the Treatment of Acute Symptoms Associated With COVID-19 (NCT04937543) | UPECLIN HC FM Botucatu Unesp | 2021-06-28 |
| Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X) (NCT04601038) | Johns Hopkins University | 2021-06-28 |
| Phase I/II Study of FR104 First Administration In Patient With Renal Transplantation: FIRsT Study (NCT04837092) | Nantes University Hospital | 2021-06-28 |
| Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder (NCT04948151) | Strategic Science & Technologies, LLC | 2021-06-28 |
| A Phase II Study to Evaluate the Efficacy and Safety of SHR-1314 in Lupus Nephritis (NCT04924296) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2021-06-28 |
| Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1 (NCT04886518) | Harmony Biosciences Management, Inc. | 2021-06-28 |
| Perioperative Treatment in Resectable Gastric Cancer With Spartalizumab (PDR001) in Combination With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel (FLOT) (NCT04736485) | Centre Francois Baclesse | 2021-06-28 |
| Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD) (NCT04931862) | Wave Life Sciences USA, Inc. | 2021-06-28 |
| Study of Magrolimab Combinations in Participants With Myeloid Malignancies (NCT04778410) | Gilead Sciences | 2021-06-28 |
| Study of FasT CAR-T GC012F Injection in High Risk TE NDMM Patients (NCT04935580) | Shanghai Changzheng Hospital | 2021-06-28 |
| Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate) (NCT04928287) | Hope Biosciences Research Foundation | 2021-06-28 |
| A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders (NCT04739423) | CuraSen Therapeutics, Inc. | 2021-06-28 |
| Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy (NCT04646005) | Regeneron Pharmaceuticals | 2021-06-28 |
| A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease (NCT04971733) | Eisai Inc. | 2021-06-28 |
| Study of ARO-ANG3 in Adults With Mixed Dyslipidemia (NCT04832971) | Arrowhead Pharmaceuticals | 2021-06-28 |
| Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer (NCT04725994) | Idience Co., Ltd. | 2021-06-28 |
| Camrelizumab Plus Apatinib for Advanced Non-Squamous NSCLC Previously Treated With First-Line Immunotherapy (NCT04670913) | Junling Li | 2021-06-28 |
| Wireless TENS for Peripheral Edema (Lower Limb Swelling) (NCT04680533) | University of Rochester | 2021-06-28 |
| Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM) (NCT04952571) | Beijing Sanbo Brain Hospital | 2021-06-27 |
| Quit Smoking Study for People Who Use E-Cigarettes (NCT04946825) | University of Vermont | 2021-06-27 |
| Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent Surgery (NCT04233073) | Alexion Pharmaceuticals, Inc. | 2021-06-27 |
| Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults (NCT04973449) | AstraZeneca | 2021-06-27 |
| Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine (NCT04962893) | Ihsan GURSEL, PhD, Prof. | 2021-06-26 |
| ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis (NCT04695080) | Queen Mary University of London | 2021-06-25 |
| Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC). (NCT04472949) | Swiss Cancer Institute | 2021-06-25 |
| Toripalimab Plus FLOT in Locally Advanced Gastric Cancer (NCT04891016) | Henan Cancer Hospital | 2021-06-25 |
| Study of Isatuximab and Cemiplimab in Relapsed or Refractory Natural Killer/T-cell Lymphoid Malignancy (NCT04763616) | Won Seog Kim | 2021-06-25 |
| Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial. (NCT04604067) | Swiss Cancer Institute | 2021-06-25 |
| A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus (NCT04785820) | Hoffmann-La Roche | 2021-06-25 |
| A Study of TQ05105 in Patients With Chronic Graft Versus Host Disease (NCT04944043) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-06-25 |
| Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008). (NCT04895722) | Merck Sharp & Dohme LLC | 2021-06-25 |
| Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast Cancer (NCT04941885) | Sun Yat-sen University | 2021-06-25 |
| IMPULSE - StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokE (NCT04124367) | Ever Neuro Pharma GmbH | 2021-06-25 |
| Effect of Trimetazidine on Radiotherapy-induced Heart Damage. (NCT04939857) | Peking University Third Hospital | 2021-06-25 |
| Phase 2 Study of RSLV-132 in Subjects With Long COVID (NCT04944121) | Resolve Therapeutics | 2021-06-25 |
| Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial. (NCT04925024) | Longeveron Inc. | 2021-06-25 |
| Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (BEHOLD) (NCT04857996) | Unity Biotechnology, Inc. | 2021-06-25 |
| A Study to Investigate the Safety of SYHA1815 in Subjects With Unresectable Locally Advanced or Metastatic Solid Tumors (NCT05105464) | Shanghai Runshi Pharmaceutical Technology Co., Ltd | 2021-06-25 |
| A Clinical Trial of Adjunctive and Monotherapy PRAX-114 in Participants With Major Depressive Disorder (NCT04969510) | Praxis Precision Medicines | 2021-06-24 |
| Regional Anesthesia in Pediatric Orthopaedic Patients (NCT04669145) | Ochsner Health System | 2021-06-24 |
| A Study of AK112 Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian Cancer (NCT04999605) | Akeso | 2021-06-24 |
| Naldebain for Pain Control After Bariatric Surgery (NCT04651361) | E-DA Hospital | 2021-06-24 |
| Exenatide for Treating Cocaine Use Disorder (NCT04941521) | The University of Texas Health Science Center, Houston | 2021-06-24 |
| Camrelizumab in Combination With Chemotherapy or Apatinib Mesylate as First-Line Treatment for R/M HNSCC (NCT05156970) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2021-06-24 |
| Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV (NCT04913272) | Kibow Pharma | 2021-06-24 |
| Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Ad5-nCoV) in Adults 18 Years of Age and Older, Living With HIV (NCT05005156) | Fundación Huésped | 2021-06-24 |
| Safety and Efficacy Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS) (NCT05103423) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2021-06-24 |
| Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis (NCT04921345) | Galderma R&D | 2021-06-24 |
| Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence (NCT05054959) | Institute of Oncology Ljubljana | 2021-06-24 |
| Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer (NCT04675710) | M.D. Anderson Cancer Center | 2021-06-24 |
| RT001 in Patients With Progressive Supranuclear Palsy (PSP) PROGRESSIVE SUPRANUCLEAR PALSY (NCT04937530) | Biojiva LLC | 2021-06-23 |
| Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer (NCT04963283) | University of Colorado, Denver | 2021-06-23 |
| A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA) (NCT04896385) | Incyte Corporation | 2021-06-23 |
| Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous Disease (NCT03983837) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-06-23 |
| Daratumumab and Pomalidomide in Previously Treated Patients With AL Amyloidosis (NCT04895917) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2021-06-23 |
| Zinc, Chromium, Vitamin C, and Copper Combination Supplement for Prediabetes Progression (NCT04511468) | Indonesia University | 2021-06-23 |
| Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (NCT05007613) | National Taiwan University Hospital | 2021-06-23 |
| Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA) (NCT04888585) | AbbVie | 2021-06-23 |
| Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI. (NCT05326425) | Jin Hyoung Kang | 2021-06-23 |
| Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo (NCT05144217) | Prof. Dr. Frank Behrens | 2021-06-23 |
| Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy (NCT04915508) | Jonsson Comprehensive Cancer Center | 2021-06-23 |
| Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis (NCT03274375) | Assistance Publique - Hôpitaux de Paris | 2021-06-23 |
| Study of SAB-176 in Healthy Adult Participants (NCT04850898) | SAb Biotherapeutics, Inc. | 2021-06-23 |
| The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer (NCT04926155) | Sun Yat-sen University | 2021-06-23 |
| Extension Study of NS-089/NCNP-02 in DMD (NCT05135663) | Nippon Shinyaku Co., Ltd. | 2021-06-23 |
| A Prospective Multicenter Clinical Study of SCCG Protocol and ctDNA 5hmc in Predicting the Chemotherapy Sensitivity and Monitoring the Recurrence and Metastasis of Hepatoblastoma in Children and Adolescents (NCT07300449) | Sun Yat-sen University | 2021-06-23 |
| Precision Therapy Versus Standard Therapy in AML and MDS in Elderly (NCT05025098) | University Hospital, Akershus | 2021-06-22 |
| The Feasibility of Performing Erector Spinae (ESP) Nerve Block in Bariatric Patients; a Case Series Study (NCT04477525) | Montefiore Medical Center | 2021-06-22 |
| A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19 (NCT04868890) | Ampio Pharmaceuticals. Inc. | 2021-06-22 |
| ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus (NCT04835441) | Alpine Immune Sciences Inc, A Subsidiary of Vertex | 2021-06-22 |
| A Clinical Studyf of SHR-1701 or Placebo in Combination With BP102 and XELOX in the First-line Treatment of mCRC (NCT04856787) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2021-06-22 |
| A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients (NCT04075916) | University of Pennsylvania | 2021-06-22 |
| A Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults (NCT04871113) | ViiV Healthcare | 2021-06-22 |
| A Study of HA121-28 Tablets in Advanced Biliary Tract Cancer (NCT04784520) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-06-22 |
| A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer (NCT04802759) | Hoffmann-La Roche | 2021-06-22 |
| Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi (NCT04585893) | UNC Lineberger Comprehensive Cancer Center | 2021-06-22 |
| A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma (NCT04996004) | Pfizer | 2021-06-22 |
| Manipulating Ghrelin Signaling Via GOAT Inhibition in Alcohol Use Disorder (NCT03896516) | National Institute on Drug Abuse (NIDA) | 2021-06-22 |
| Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma (NCT04710498) | Stanford University | 2021-06-22 |
| ASTX727 and Donor Lymphocyte Infusions After Allogenic Stem Cell Transplantation in Very High Risk MDS or AML Patients (NCT04857645) | Groupe Francophone des Myelodysplasies | 2021-06-22 |
| A Study of Toripalimab as Consolidation Therapy After Postoperative Chemoradiotherapy in HNSCC (NCT04992559) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-06-22 |
| APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation (NCT04858334) | National Cancer Institute (NCI) | 2021-06-22 |
| A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy (NCT04958031) | AbbVie | 2021-06-22 |
| Cardiorespiratory Fitness in Children and Adolescents After Cancer Treatment. (NCT04765020) | Universität Duisburg-Essen | 2021-06-21 |
| Pharmacokinetic Study of Linezolid for TB Meningitis (NCT03537495) | Universitas Padjadjaran | 2021-06-21 |
| MIT-001 for Prevention of CCRT-Induced OM in HNSCC Patients (NCT04651634) | MitoImmune Therapeutics | 2021-06-21 |
| Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy (NCT04883346) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2021-06-21 |
| Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C (NCT05395416) | Sunshine Lake Pharma Co., Ltd. | 2021-06-21 |
| Avexitide Safety and Efficacy to Treat Acquired Hyperinsulinemic Hypoglycemia (NCT04652479) | Dr. Tracey McLaughlin, MD | 2021-06-21 |
| Vitamin A Supplementation in Children With Moderate to Severe COVID-19 (NCT04920760) | Shiraz University of Medical Sciences | 2021-06-21 |